Efficacy and Safety Profile of Remimazolam-alfentanil Combination for ERCP Sedation
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
Moderate to deep levels of sedation and analgesia are required for ERCP. Propofol-based
sedation is simple, easy to use, and effective, but is not without cardiovascular and
respiratory adverse effects. The combination of remimazolam and alfentanil has shown
promising results for sedation in other similar scenarios. The aim of this study was to
compare the efficacy and safety of a standard propofol-alfentanil regimen with a
remimazolam-alfentanil combination.